Wiktionary
otelixizumab
n. A monoclonal antibody being developed for the treatment of type 1 diabetes and other autoimmune diseases.
Wikipedia
Otelixizumab
Otelixizumab, also known as TRX4, is a monoclonal antibody, which is being developed for the treatment of type 1 diabetes and other autoimmune diseases. The antibody is being developed by Tolerx, Inc. in collaboration with GlaxoSmithKline and is being manufactured by Abbott Laboratories.